Valneva SE
- VALN
- NASDAQ
- Biotechnology
- Vaccine Development
- Infectious Disease Vaccines
$5.61
Today −5.08%Quote Oct 16, 2026, 08:00 PM UTC
−14.61%over the last month
Max drawdown −16.0%From 1-month high −15.3%3 months +15.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$973.6M
Quote Oct 16
Next earnings
Nov 19
Expected, not confirmed
Analyst target
$17.00
+203.0% from here
Floor
$5.59
0.3% below price
Where the price sits
3 analysts
Analyst range, low to high
$11.00$26.00
- Price $5.61
- Resistance $5.81
- Consensus $17.00
The price is just above its floor. Analysts' average target sits about 203% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VALNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
674
Founded
1998